Consensus Lineage Cell Therapeutics, Inc.

Equities

LCTX

US53566P1093

Market Closed - Nyse 04:00:00 2024-02-28 pm EST 5-day change 1st Jan Change
1.04 USD -4.59% Intraday chart for Lineage Cell Therapeutics, Inc. -1.89% -4.59%

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
5
Last Close Price
1.04 USD
Average target price
5.4 USD
Spread / Average Target
+419.23%
High Price Target
7 USD
Spread / Highest target
+573.08%
Low Price Target
4 USD
Spread / Lowest Target
+284.62%

Consensus detail

Consensus revision (last 18 months)

Analysts covering Lineage Cell Therapeutics, Inc.

Baird
B. Riley
Noble Capital
Chardan
Cantor Fitzgerald
Trading Rating
Investor Rating
ESG Refinitiv
C
More Ratings
  1. Stock
  2. Equities
  3. Stock Lineage Cell Therapeutics, Inc. - Nyse
  4. Consensus Lineage Cell Therapeutics, Inc.
-40% Limited-time offer: Our subscriptions help you unlock the best investment opportunities.
SIGN UP NOW